Oppenheimer & Co’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,254
Closed -$236K 1740
2025
Q4
$236K Sell
7,254
-37,448
-84% -$1.6M ﹤0.01% 1369
2025
Q3
$2.54M Buy
44,702
+15,219
+52% +$780K 0.03% 532
2025
Q2
$1.47M Sell
29,483
-9,806
-25% -$443K 0.02% 685
2025
Q1
$1.16M Buy
39,289
+3,079
+9% +$114K 0.02% 740
2024
Q4
$876K Buy
+36,210
New +$897K 0.01% 845

Other funds holding HIMS

Oppenheimer & Co's HIMS Position: Q1 2026 in Review

Oppenheimer & Co sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 7,254 shares — an estimated $236K sold.

Oppenheimer & Co first reported a position in HIMS in Q4 2024 and held it in 5 quarters. The position peaked at $2.54M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Oppenheimer & Co reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Oppenheimer & Co sold 7,254 Hims & Hers Health shares in Q1 2026, an estimated $236K.
  • Oppenheimer & Co first reported a position in Hims & Hers Health in Q4 2024 and held it in 5 quarters.
  • Oppenheimer & Co's Hims & Hers Health position peaked at $2.54M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.